Other weight-loss drugs are currently in development or regulatory approval stages, including: Once-daily GLP-1 pill orforglipron (Eli Lilly), which, when taken alongside a healthy diet and exercise, resulted in a 7.5% weight loss over 72 weeks on the 6mg dose, 8.4% loss with 12mg of orforglipron, and 11.2% loss with 36mg of orforglipron, as compared with 2.1% loss with placebo (funded by Eli Lilly
Treatment with glucose-lowering agent(s) within 90 days before screening
Molecular Devices), and analysed on a computer running pCLAMP 10 software (Molecular Devices)
To help, healthcare providers prescribe GLP-1 medicines in combination with diet, exercise, and even other medicines
Specific probiotic strains help maintain the digestive health crucial for long-term success
Meet the team of leading specialists with decades of combined experience across key specialties.